Mahmud et al. [81] reviewed the pharmacological potential of cannabinoids on the SARS-CoV-2 virus and concluded that intranasal administration of CBD led to a decrease in the pro-inflammatory secretion of the cytokine IL-6, resulting in an improvement in symptoms associated with COVID-19. This evidence concerns the gene IL6 and COVID-19.